Documentos relacionados

1. Tocilizumab en pacientes con artritis reumatoide activa y respuesta inadecuada a fármacos antirreumáticos modificadores de la enfermedad o antagonistas del factor de necrosis tumoral: subanálisis de los datos españoles de un estudio abierto cercano a la práctica clínica habitual
2. IL-6 inhibitor for the treatment of rheumatoid arthritis: A comprehensive review.
3. [Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Best practice of IL-6 inhibitors.]
4. Olokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis.
5. Risk of herpes zoster (shingles) in patients with rheumatoid arthritis under biologic, targeted synthetic and conventional synthetic DMARD treatment: data from the German RABBIT register.
6. [Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Anti-bone resorbing treatment for rheumatoid arthritis.]
7. Sex Differences in the Treatment of Psoriatic Arthritis: A Systematic Literature Review.
8. Subcutaneous Tocilizumab Is Effective for Treatment of Elderly-Onset Rheumatoid Arthritis.
9. Interleukin-6 in juvenile idiopathic arthritis.
10. Targets of biologic disease-modifying antirheumatic drugs and risk of multiple myeloma.